Science Explorer Back to mapMap

Most cited papers from Ehime Prefectural Central Hospital

What are the most cited papers from Ehime Prefectural Central Hospital?

The most cited paper from Ehime Prefectural Central Hospital is "Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI" (Hirotoshi Watanabe et al., 2019), with 861 citations. Next come "Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update" (689) and "JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan" (635).

Showing 50 of 60 papers. Every paper with more than 83 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI Hirotoshi Watanabe et al. · JAMA Open access 25 Jun 2019 861
2 Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 Update Masatoshi Kudo et al. · Liver Cancer Open access 2021 689
3 JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan Masatoshi Kudo, Osamu Matsui, Namiki Izumi et al. · Liver Cancer Open access 2014 635
4 Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function Atsushi Hiraoka, Kojiro Michitaka, Takashi Kumada et al. · Liver Cancer Open access 2017 343
5 Laparoscopic percutaneous extraperitoneal closure for inguinal hernia in children: clinical outcome of 972 repairs done in 3 pediatric surgical institutions Hiroo Takehara, Shigeru Yakabe, Kazuhiro Kameoka · Journal of Pediatric Surgery Dec 2006 320
6 Fulminant Type 1 Diabetes Akihisa Imagawa, Toshiaki Hanafusa, Yasuko Uchigata et al. · Diabetes Care Aug 2003 296
7 Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study Masakatsu Hishizawa et al. · Blood 17 May 2010 293
8 Transarterial Chemoembolization Failure/Refractoriness: JSH-LCSGJ Criteria 2014 Update Masatoshi Kudo, Osamu Matsui, Namiki Izumi et al. · Oncology 2014 284
9 Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter Analysis Atsushi Hiraoka, Takashi Kumada, Kunihiko Tsuji et al. · Liver Cancer Open access 11 Jun 2018 256
10 Usefulness of albumin–bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma Atsushi Hiraoka, Takashi Kumada, Kojiro Michitaka et al. · Journal of Gastroenterology and Hepatology Open access 9 Dec 2015 251
11 Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation Atae Utsunomiya, Yasushi Miyazaki, Yoshifusa Takatsuka et al. · Bone Marrow Transplantation 2001 244
12 A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19 Yohei Doi et al. · Antimicrobial Agents and Chemotherapy Open access 22 Sep 2020 238
13 The G/G Genotype of a Resistin Single-Nucleotide Polymorphism at −420 Increases Type 2 Diabetes Mellitus Susceptibility by Inducing Promoter Activity through Specific Binding of Sp1/3 Haruhiko Osawa, Kazuya Yamada, Hiroshi Onuma et al. · The American Journal of Human Genetics Open access 12 Sep 2004 233
14 Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications Atsushi Hiraoka, Takashi Kumada, Masatoshi Kudo et al. · Liver Cancer Open access 2017 218
15 Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial Hiromichi Hamada et al. · The Lancet 109 authors Mar 2019 214
16 Clinical significance of global two-dimensional strain as a surrogate parameter of myocardial fibrosis and cardiac events in patients with hypertrophic cardiomyopathy Makoto Saito, Hideki Okayama, Toshitaka Yoshii et al. · European Heart Journal - Cardiovascular Imaging 12 Jan 2012 197
17 Comparison of ultrasound-guided erector spinae plane block and thoracic paravertebral block for postoperative analgesia after video-assisted thoracic surgery: a randomized controlled non-inferiority clinical trial Yasuko Taketa, Yumi Irisawa, Taro Fujitani · Regional Anesthesia & Pain Medicine 8 Nov 2019 174
18 Enhanced Inflammation in Epicardial Fat in Patients With Coronary Artery Disease Yoichiro Hirata, Hirotsugu Kurobe, Masashi Akaike et al. · International Heart Journal Open access 2011 174
19 Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysis Atsushi Hiraoka et al. · Cancer Medicine Open access 24 May 2019 159
20 Spinal Muscular Atrophy: The Past, Present, and Future of Diagnosis and Treatment Hisahide Nishio, Emma Tabe Eko Niba, Toshio Saito et al. · International Journal of Molecular Sciences Open access 26 Jul 2023 156
21 Macroregenerative nodule of the liver.A clinicopathologic study of 345 autopsy cases of chronic liver disease Keizo Furuya, Muneo Nakamura, Yosuke Yamamoto et al. · Cancer 1988 156
22 Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter Analysis Atsushi Hiraoka, Takashi Kumada, Masatoshi Kudo et al. · Digestive Diseases 2017 154
23 Disease-associated CIAS1 mutations induce monocyte death, revealing low-level mosaicism in mutation-negative cryopyrin-associated periodic syndrome patients Megumu K. Saito, Ryuta Nishikomori, Naotomo Kambe et al. · Blood Open access 6 Dec 2007 151
24 Apathy and Depression in Parkinson Disease Miyako Oguru, Hisao Tachibana, Kazuo Toda et al. · Journal of Geriatric Psychiatry and Neurology 15 Dec 2009 151
25 Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study Kazuomi Ueshima, Naoshi Nishida, Satoru Hagiwara et al. · Cancers Open access 7 Jul 2019 144
26 Pregnancy‐induced thrombocytopenia and TTP, and the risk of fetal death, in Upshaw–Schulman syndrome: a series of 15 pregnancies in 9 genotyped patients Yoshihiro Fujimura, Masanori Matsumoto, Koichi Kokame et al. · British Journal of Haematology Dec 2008 144
27 Newly Proposed ALBI Grade and ALBI-T Score as Tools for Assessment of Hepatic Function and Prognosis in Hepatocellular Carcinoma Patients Atsushi Hiraoka, Takashi Kumada, Kojiro Michitaka et al. · Liver Cancer Open access 29 Nov 2018 140
28 Granule exocytosis, and not the Fas/Fas ligand system, is the main pathway of cytotoxicity mediated by alloantigen-specific CD4+ as well as CD8+ cytotoxic T lymphocytes in humans Masaki Yasukawa, Hideki Ohminami, Junko A. Arai et al. · Blood Apr 2000 137
29 Atezolizumab plus bevacizumab versus lenvatinib for unresectable hepatocellular carcinoma: a large real-life worldwide population Andrea Casadei Gardini et al. · European Journal of Cancer Open access 25 Nov 2022 135
30 Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis Atsushi Hiraoka et al. · European Journal of Gastroenterology & Hepatology 10 Oct 2017 135
31 PREOPERATIVE TRANSCATHETER EMBOLIZATION OF THE PORTAL VENOUS BRANCH FOR PATIENTS RECEIVING EXTENDED LOBECTOMY DUE TO THE BILE DUCT CARCINOMA Masatoshi Makuuchi, Kenichi Takayasu, Tetsuo Takuma et al. · The journal of the Japanese Practical Surgeon Society Open access 1984 135
32 Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis Margherita Rimini et al. · ESMO Open Open access 5 Oct 2022 132
33 Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysis Atsushi Hiraoka et al. · Cancer Medicine Open access 21 Dec 2018 132
34 Clinical, Autoimmune, and Genetic Characteristics of Adult-Onset Diabetic Patients With GAD Autoantibodies in Japan (Ehime Study) Haruyo Takeda et al. · Diabetes Care Open access Jun 2002 126
35 Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study Junya Kanda et al. · Blood 11 Jan 2012 126
36 Screening for Dry Eye With Newly Developed Ocular Surface Thermographer Tomoyuki Kamao, Masahiko Yamaguchi, Shiro Kawasaki et al. · American Journal of Ophthalmology 19 Feb 2011 123
37 Different contribution of class II HLA in fulminant and typical autoimmune type 1 diabetes mellitus Akihisa Imagawa, Toshiaki Hanafusa, Yasuko Uchigata et al. · Diabetologia Open access Feb 2005 121
38 Anxiety and Depression in Patients with Parkinson's Disease Toshiyuki Yamanishi, Hisao Tachibana, Miyako Oguru et al. · Internal Medicine Open access 2013 120
39 The Role of Neutrophils in the Pathogenesis of Idiopathic Pulmonary Fibrosis Yuka Obayashi, I Yamadori, Jiro Fujita et al. · CHEST Journal Nov 1997 120
40 World Congress Integrative Medicine & Health 2017: Part one Benno Brinkhaus et al. · BMC Complementary and Alternative Medicine Open access784 authors Jun 2017 116
41 Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD: A Randomized Clinical Trial Kazuma Nagata et al. · American Journal of Respiratory and Critical Care Medicine Open access 30 Jun 2022 114
42 Cryptogenic NORSE Takahiro Iizuka, Naomi Kanazawa, Juntaro Kaneko et al. · Neurology Neuroimmunology & Neuroinflammation Open access 26 Sep 2017 111
43 Muscle atrophy as pre-sarcopenia in Japanese patients with chronic liver disease: computed tomography is useful for evaluation Atsushi Hiraoka, Toshihiko Aibiki, Tomonari Okudaira et al. · Journal of Gastroenterology Open access 30 Mar 2015 109
44 Sinusoidal obstruction syndrome after allogeneic hematopoietic stem cell transplantation: Incidence, risk factors and outcomes Kimikazu Yakushijin, Yoshiko Atsuta, Noriko Doki et al. · Bone Marrow Transplantation 23 Nov 2015 108
45 Enhancement of antitumor activity by using 5-ALA–mediated sonodynamic therapy to induce apoptosis in malignant gliomas: significance of high-intensity focused ultrasound on 5-ALA-SDT in a mouse glioma model Satoshi Suehiro, Takanori Ohnishi, Daisuke Yamashita et al. · Journal of neurosurgery 19 Jan 2018 106
46 Remote ischemic preconditioning reduces contrast-induced acute kidney injury in patients with ST-elevation myocardial infarction: A randomized controlled trial Toshiaki Yamanaka, Yusuke Kawai, Toru Miyoshi et al. · International Journal of Cardiology Open access 23 Oct 2014 106
47 The GCKR rs780094 polymorphism is associated with susceptibility of type 2 diabetes, reduced fasting plasma glucose levels, increased triglycerides levels and lower HOMA-IR in Japanese population Hiroshi Onuma, Yasuharu Tabara, Ryuichi Kawamoto et al. · Journal of Human Genetics 24 Jun 2010 101
48 Neutrophil‐to‐lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinib Toshifumi Tada et al. · Liver International Open access 17 Feb 2020 97
49 Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib Atsushi Hiraoka et al. · Hepatology Research 2 Aug 2016 96
50 Assessment of Reperfused Acute Myocardial Infarction with Two-Phase Contrast-enhanced Helical CT: Prediction of Left Ventricular Function and Wall Thickness Yasushi Koyama, Hiroshi Matsuoka, Teruhito Mochizuki et al. · Radiology Jun 2005 96

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.